Ribasphere Three Rivers Pharmaceuticals - Treatment for Hepatitis C ("HCV")
The U.S. Food and Drug Administration (FDA) has granted marketing approval for Ribasphere (ribavirin capsules) 200mg in combination with interferon alfa-2b for the treatment of Hepatitis C ("HCV").Posted: April 2004
Ribasphere (ribavirin) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
